Private company

Mundipharma

Logo: Unknown author Unknown author, Public domain, via Wikimedia Commons³

British multinational pharmaceutical company

Mundipharma International Limited is a British multinational research-based pharmaceutical company owned by members of the Sackler family with locations in United Kingdom, Canada, Germany, China, and Singapore. In Germany, Mundipharma is a subsidiary of Mundipharma International Limited and Mundipharma AG. Its global headquarters is located at the Cambridge Science Park of Cambridge, England.² Its chief executive is Marc Princen (since 2020).¹ Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

1967Founded¹

Industrypharmaceutical industry¹
HeadquartersLimburg an der Lahn¹
Websitewww.mundipharma.de
Legal formGesellschaft mit beschränkter Haftung¹

See how the biggest companies compare on our leaderboards

The story

The company was founded in 1967 in Frankfurt, Germany by the brothers Raymond and Mortimer Sackler, the owners of Purdue Pharma at the time. Between 1970 and 1974 two pharmaceutical companies were acquired. It was the chemical-pharmaceutical factory Krugmann GmbH and the pharmaceutical factory Dr. med. Hans Voigt GmbH. In 1975 the company moved to Limburg an der Lahn in Germany.

The first factory building was designed in 1973 by architect Marcel Breuer and built in the Dietkircher Höhe industrial park. The last completion of a structural expansion took place in 2010.

The company is exploring a sale as part of the Purdue Pharma bankruptcy process and Sackler family settlement. It could fetch as much as $5 billion according to Bloomberg News.

From Wikipedia’s article on Mundipharma, shared under CC BY-SA 4.0.⁴

Leadership

Who has led Mundipharma, and when. Pick a name to see everywhere that person has worked.

Chief executive

Marc Princen2020–now

197019801990200020102020

Chief executive officerMarc Princen Jun 1, 2020 to now¹

Controversies and legal

Criticism

Tobacco industry collaboration

Mundipharma has been condemned by healthcare professionals for its April 16th 2024 announcement that it had entered into a collaboration with Vectura, a company owned by Tobacco Transnational Philip Morris.

Opioid marketing

In relation the opioid epidemic Mundipharma has been criticized for using similar methods to Purdue Pharma to sell opioids in Europe.

Nyxoid

Mundipharma has marketed a brand of Naloxone called Nyxoid which was criticized for its prices and for Purdue's involvement in the Opioid crisis.